Not included in the new recommendations and labeling are bisphosphonate drugs that are used only to treat Paget's disease or malignancy-associated hypercalcemia (DIDRONEL, ZOMETA, SKELID ...

Bisphosphonates are prescription drugs that improve bone density. They’re used to treat several conditions associated with bone loss, including osteoporosis, and to reduce the risk of fractures.

Magnesium-rich supplements can decrease the absorption of oral bisphosphonates, a family of drugs used to treat osteoporosis, ...

Background and Objective: Despite their widespread use in metastatic bone disease, some bisphosphonate drugs are associated with adverse events (AEs), particularly renal toxicity, adding to ...

They have individual side effects. The list includes chemotherapy, hormone therapies, targeted cancer drugs, immunotherapy drugs and bisphosphonates. The drugs are listed in alphabetical order by ...

This class of drugs is currently in decline as newer agents are developed. Bone calcium regulators, including bisphosphonates such as Fosamax (alendronic acid; Merck) and Actonel (risedronic acid ...